MSD Animal Health Opens State-Of-The-Art Manufacturing Facility in Boxmeer, the Netherlands, for Companion Animal vaccines

Dutch Minister Micky Adriaansens attends official facility opening

Facility capacity to meet increased global customer demand for our innovative vaccines

BOXMEER, the Netherlands, Jan. 23, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the opening of a state-of-the-art manufacturing facility in Boxmeer, the Netherlands, for sterile filling and freeze drying of Companion Animal vaccines. Boxmeer is one of the company’s centers for the development and production of veterinary vaccines. The location is part of a manufacturing network in the Netherlands, including existing production and research facilities in Boxmeer and De Bilt that supports the company’s global leadership position in the animal health vaccine market.

The company held a formal ribbon-cutting ceremony in Boxmeer to officially mark this milestone, which was attended by Dutch Minister for Economic Affairs and Climate Micky Adriaansens and President of MSD Animal Health Rick DeLuca.

“Innovation contributes to our future economy. This new MSD Animal Health manufacturing facility demonstrates that the Dutch life science and health sector is leading in Europe,” said Dutch Minister of Economic Affairs and Climate Policy Mickey Adriaansens. “In Boxmeer, products are made that contribute to the protection of both human and animal health.”

“We are excited about the opportunity to build on our advanced technology within the Boxmeer facility and expand our footprint in the Netherlands,” said Rick DeLuca, president, MSD Animal Health. “As a leader in delivering innovative biopharmaceuticals and technology solutions to advance animal health, this investment reflects our commitment to produce a range of innovative animal health medicines, vaccines and technology to meet increased customer demand for our growing portfolio of products and solutions.”   

The new manufacturing facility will include production capacity for sterile filling and freeze drying of vaccines and will provide MSD Animal Health with additional manufacturing resources to meet the growing customer demand.

Vaccines play an important role in protecting animal and public health. Timely and effective vaccination reduces the incidence and severity of disease, enabling efficient production of food animals. Vaccines also have had a significant impact on the health of pets, preventing serious illnesses and helping them live longer and healthier lives.

We continually seek new ways to improve and enhance our manufacturing and production capacity and capabilities at our facilities around the world to meet the growing needs of our animal health customers, including our Boxmeer facility,” said Matt Shields, senior vice president, Animal Health Manufacturing, MSD Animal Health. “Our investments in manufacturing, which have included a large-scale production facility in Krems, Austria, and a vaccine production facility in Salamanca, Spain, demonstrate our commitment to help farmers, producers and veterinarians advance the health of animals and support a safe food supply.

MSD Animal Health also continues to invest in expanding existing manufacturing facilities on the Boxmeer site, which employs 2,000 employees, mainly in research and development and manufacturing roles.

About MSD Animal Health

At MSD, known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is the global animal health business of MSD. Through its commitment to The Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit and connect with us on LinkedIn and Twitter.